Regeneron Drug Lowers LDL for Patients Who Cant Take Statins

Nov 18, 2014, 00:00 by Michael Croft

Reuters | Just a day after Merck reported strong results from its IMPROVE-IT Vytorin trial, Regeneron presented its own clinical trial saying its drug helped 10 times as many patients lower their LDL.

November 18, 2014 | Just a day after Merck reported strong results from its IMPROVE-IT Vytorin trial, Regeneron presented its own clinical trial saying its drug helped 10 times as many patients lower their LDL. Reuters